The goal of the MD Anderson/Rice Cancer Nanotech T32 Fellowship is to train scientists who will transfer the great promise of nanotechnology into clinical reality. This novel training program educates future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, who are keenly aware of the needs and demands of clinical environment as well as of major challenges of translational research. This is a two-tiered program: the Predoctoral Program provides mentorship, training, and funding for 2 years to students who have been accepted into the Ph.D. program in bioengineering, chemistry, or applied physics at Rice University and have completed 1 or 2 years of their didactic coursework; and the Postdoctoral Program provides a 2-year fellowship to recent Ph.D. awardees with training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology. Each fellow will be co-mentored by two program faculty - one from MD Anderson Cancer Center and one from Rice University. Detailed information can also be found on the T32 Program Flyer. Program eligibility: per program requirement fellows "must be a citizen of the United States or have been lawfully admitted for permanent residence at the time of appointment."
T32 Predoctoral Fellow Emily Reiser Evans
receives Outstanding Poster Award at the
NIH Alliance for Nanotechnology in
Cancer 2016 Meeting